.

Pharmaceutical Business Intelligence

  • Anticipate P&T budget requirements
  • Evaluate market entry opportunities
  • Find generic sources and suppliers
  • Predict branded drug patent expiration

► Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

DrugPatentWatch Database Preview

Details for Patent: 5,456,901

« Back to Dashboard

Details for Patent: 5,456,901

Title: Liposomes as contrast agents for ultrasonic imaging
Abstract:Liposomes suitable as ultrasound contrast agents which contain media of various types including gases, gaseous precursors activated by pH, temperature or pressure, as well as other solid or liquid contrast enhancing agents, are described. Methods of using the same as ultrasound contrast agents are also disclosed. The present invention also comprises novel methods for synthesizing liposomes having encapsulated therein gases.
Inventor(s): Unger; Evan C. (Tucson, AZ)
Assignee:
Filing Date:Feb 28, 1995
Application Number:08/395,683
Claims:1. A method of providing an image of an internal region of a patient comprising:

(a) administering to the patient a liposome having encapsulated therein a solid contrast enhancing agent selected from the group consisting of magnetite and solid iodine particles, or a liquid contrast enhancing agent selected from the group consisting of solubilized iodinated compounds; and

(b) scanning the patient using ultrasonic imaging to obtain visible images of the region.

2. The method according to claim 1 wherein said liposomes are administered intravascularly, and the vesicles have a mean outer diameter of between about 30 nanometers and about 2 microns.

3. The method according to claim 2; wherein the patient is scanned in the area of the patient's heart.

4. The method according to claim 2 wherein the patient is scanned in the area of the patient's arterial system.

5. The method according to claim 2 wherein the patient is scanned in the area of the patient's venous system.

6. The method according to claim 2 wherein the patient is scanned in the area of the patient's liver, spleen and kidney.

7. The method according to claim 1 wherein the liposomes are administered other than intravascularly and have a mean outer diameter between about 2 microns and about 10 microns.

8. The method of claim 1 wherein the liposomes are comprised of lipids of either natural or synthetic origin selected from the group consisting of fatty acids, lysolipids, dipalmitoylphosphatidylcholine, phosphatidylcholine, phosphatidylethanolamine, phosphatidylglycerol, phosphatidylserine, phosphatidic acid, phosphatidylinositol, sphingomyelin, lysolipids, cholesterol, cholesterol hemisuccinate, glycosphingolipids, glycolipids, glucolipids, sulphatides, and tocopherol hemisuccinate.

9. A method for diagnosing the presence of diseased tissue in a patient comprising:

(a) administering to the patient a liposome having encapsulated therein a solid contrast enhancing agent selected from the group consisting of magnetite and solid iodine particles, or a liquid contrast enhancing agent selected from the group consisting of solubilized iodinated compounds; and

(b) scanning the patient using ultrasonic imaging to obtain visible images of any diseased tissue in the patient.

10. A method according to claim 1 wherein said contrast enhancing agent is a solid selected from the group consisting of magnetite and solid iodine particles.

11. A method according to claim 11 wherein said solid iodine particles are selected from the group consisting of iodipamide ethyl ester and metricate.

12. A method according to claim 11 wherein said solid iodine particles are iodipamide ethyl ester.

13. A method according to claim 1 wherein said contrast enhancing agent is a liquid selected from the group consisting of solubilized iodinated compounds.

14. A method according to claim 9 wherein said liposomes are administered intravascularly, and the vesicles have a mean outer diameter of between about 30 nanometers and about 2 microns.

15. A method according to claim 14 wherein the patient is scanned in the area of the patient's heart.

16. A method according to claim 14 wherein the patient is scanned in the area of the patient's arterial system.

17. A method according to claim 14 wherein the patient is scanned in the area of the patient's venous system.

18. A method according to claim 14 wherein the patient is scanned in the area of the patient's liver, spleen and kidney.

19. A method according to claim 9 wherein the liposomes are administered other than intravascularly and have a mean outer diameter between about 2 microns and about 10 microns.

20. A method of claim 9 wherein the liposome is comprised of lipid selected from the group consisting of fatty acids, lysolipids, dipalmitoylphosphatidylcholine, phosphatidylcholine, phosphatidylethanolamine, phosphatidylglycerol, phosphatidylserine, phosphatidic acid, phosphatidylinositol, sphingomyelin, lysolipids, cholesterol, cholesterol hemisuccinate, glycosphingolipids, glycolipids, glucolipids, sulphatides, and tocopherol hemisuccinate.

21. A method according to claim 9 wherein said contrast enhancing agent is a solid selected from the group consisting of magnetite and solid iodine particles.

22. A method according to claim 20 wherein said solid iodine particles are selected from the group consisting of iodipamide ethyl ester and metricate.

23. A method according to claim 22 wherein said solid iodine particles are iodipamide ethyl ester.

24. A method according to claim 9 wherein said contrast enhancing agent is a liquid selected from the group consisting of solubilized iodinated compounds.
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

How are People Using DrugPatentWatch?

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

`abc